Search

everythinglearnresearchcommunity

for

Search:↓

A specific gene region can control targeted and responsive gene expression in mice, useful for skin disorder treatments.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

Overexpression of ALK2 in hair follicles disrupts skin development and slows wound healing.

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

The UHS promoter is specific to mouse hair follicles.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

A specific gene mutation causes woolly hair and hair loss.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

A family was found with both Trichorhinophalangeal syndrome and Loose Anagen Syndrome, suggesting a genetic connection.

Activating TLR3 boosts autophagy gene expression in skin cells.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

HDMHG0401-10 improves hair loss in men with androgenetic alopecia and has no major side effects.

HLA-DRB5 and other genes may be linked to alopecia universalis.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

Follicular targeting could improve hirsutism treatment by focusing directly on hair follicles.

Retinoic acid reduces cell damage from oxidative stress.

The plant extract may help prevent hair loss by reducing inflammation and promoting hair growth.

New treatments for excessive hair growth in women, including advanced drugs and nanotechnology, show promise for better results.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Girls with prepubertal simple hypertrichosis have higher dihydrotestosterone (DHT) levels.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

THH and PAD type III appear together early in hair growth, but deiminated THH appears later, suggesting another factor is involved.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.